860757-12-6Relevant articles and documents
Identification of novel triazole inhibitors of Wnt/β-catenin signaling based on the Niclosamide chemotype
Mook, Robert A.,Wang, Jiangbo,Ren, Xiu-Rong,Piao, Hailan,Lyerly, H. Kim,Chen, Wei
, p. 317 - 321 (2019)
Dysregulation of the Wnt signaling pathway is an underlying mechanism in multiple diseases, particularly in cancer. Until recently, identifying agents that target this pathway has been difficult and as a result, no approved drugs exist that specifically t